{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:32Z","timestamp":1786118912402,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/bor.0b013e3282ff0d6d","type":"journal-article","created":{"date-parts":[[2008,6,2]],"date-time":"2008-06-02T03:05:29Z","timestamp":1212375929000},"page":"435-441","source":"Crossref","is-referenced-by-count":11,"title":["Incidence and prevalence of medication-induced osteoporosis: evidence-based review"],"prefix":"10.1097","volume":"20","author":[{"given":"Juliette","family":"Allport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","article-title":"Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs","volume":"87","author":"Mittan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","article-title":"Progressive osteoporosis during androgen deprivation therapy for prostate cancer","volume":"163","author":"Daniell","year":"2000","journal-title":"J Urol"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1200\/JCO.2005.03.903","article-title":"Aromatase inhibitors and bone loss: risks in perspective","volume":"23","author":"Shapiro","year":"2005","journal-title":"J Clin Oncol"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1346.057","article-title":"Pathogenesis of osteopenia\/osteoporosis induced by highly active anti-retroviral therapy for AIDS","volume":"1068","author":"Pan","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","article-title":"Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures","volume":"167","author":"Diem","year":"2007","journal-title":"Arch Intern Med"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1176\/appi.ajp.160.9.1618","article-title":"Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study","volume":"160","author":"Abraham","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10401230500464687","article-title":"Bone mineral density in male schizophrenia patients: a review","volume":"18","author":"Meyer","year":"2006","journal-title":"Ann Clin Psychiatry"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/humrep\/14.11.2876","article-title":"Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study","volume":"14","author":"Backos","year":"1999","journal-title":"Hum Reprod"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/jbmr.5650101209","article-title":"Predictors of hip fractures in elderly men","volume":"10","author":"Poor","year":"1995","journal-title":"J Bone Miner Res"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-410X.2007.07163.x","article-title":"Fracture risk in Danish men with prostate cancer: a nationwide register study","volume":"100","author":"Abrahamsen","year":"2007","journal-title":"BJU Int"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","article-title":"Risk of hip fracture in patients with a history of schizophrenia","volume":"190","author":"Howard","year":"2007","journal-title":"Br J Psychiatry"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2006.07.022","article-title":"Fracture risk in users of oral anticoagulants: a nationwide case-control study","volume":"118","author":"Rejnmark","year":"2007","journal-title":"Int J Cardiol"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1081-1206(10)60941-6","article-title":"High-dose corticosteroid exposure and osteoporosis intervention in adults","volume":"97","author":"Che","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","article-title":"Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients","volume":"52","author":"Curtis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.mpg.0000228105.91240.80","article-title":"Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment","volume":"43","author":"Walther","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/thorax.55.9.798","article-title":"Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors","volume":"55","author":"Conway","year":"2000","journal-title":"Thorax"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/thorax.56.4.279","article-title":"Adverse effects of oral corticosteroids in relation to dose in patients with lung disease","volume":"56","author":"Walsh","year":"2001","journal-title":"Thorax"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1080\/10428190701471973","article-title":"Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures","volume":"48","author":"Cabanillas","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","article-title":"Use of inhaled corticosteroids and risk of fractures","volume":"16","author":"van Staa","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","article-title":"Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis","volume":"12","author":"Zorzon","year":"2005","journal-title":"Eur J Neurol"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00198-004-1799-7","article-title":"Fracture risk in patients with prostate cancer on androgen deprivation therapy","volume":"16","author":"Lopez","year":"2005","journal-title":"Osteoporos Int"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.20388","article-title":"Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy","volume":"101","author":"Krupski","year":"2004","journal-title":"Cancer"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3816\/CBC.2006.n.021","article-title":"Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors","volume":"7","author":"Mincey","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"R33-11-20210128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/135965350701200701","article-title":"The association of bone mineral density with HIV infection and antiretroviral treatment in women","volume":"12","author":"Anastos","year":"2007","journal-title":"Antivir Ther"},{"key":"R34-11-20210128","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"Aids"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O'Keane","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R37-11-20210128","first-page":"1305","article-title":"Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study","volume":"31","author":"di Munno","year":"2004","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282ff0d6d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:02:21Z","timestamp":1786035741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200807000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282ff0d6d","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}